Evidence map›Paper›PMID 32184962›Full record

ArticleACS medicinal chemistry letters2020

Regioisomeric Family of Novel Fluorescent Substrates for SHIP2.

Gaye White, Christopher Prior, Stephen J Mills, Kendall Baker, Hayley Whitfield, Andrew M Riley, Vasily S Oganesyan, Barry V L Potter, Charles A Brearley

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS medicinal chemistry letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Gaye WhiteSchool of Biological Sciences, UEA, Norwich Research Park, Norwich NR4 7TJ, U.K.
Christopher PriorSchool of Chemistry, UEA, Norwich Research Park, Norwich NR47TJ, U.K.
Stephen J MillsMedicinal Chemistry & Drug Discovery, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K.
Kendall BakerSchool of Biological Sciences, UEA, Norwich Research Park, Norwich NR4 7TJ, U.K.
Hayley WhitfieldSchool of Biological Sciences, UEA, Norwich Research Park, Norwich NR4 7TJ, U.K.
Andrew M RileyMedicinal Chemistry & Drug Discovery, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K.
Vasily S OganesyanSchool of Chemistry, UEA, Norwich Research Park, Norwich NR47TJ, U.K.
Barry V L PotterMedicinal Chemistry & Drug Discovery, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K.
Charles A BrearleySchool of Biological Sciences, UEA, Norwich Research Park, Norwich NR4 7TJ, U.K.
Norwich Research Park · GBMansfield University · US

Funding

Biotechnology and Biological Sciences Research Council BB/N002024/1Wellcome Trust 101010
6 · The paper itself

Abstract

SHIP2 (SH2-domain containing inositol 5-phosphatase type 2) is a canonical 5-phosphatase, which, through its catalytic action on PtdInsP

Identifiers

PMID32184962
PMCPMC7073872
OpenAlexW2980765121

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.